Targeting the Type 5 Metabotropic Glutamate Receptor: A Potential Therapeutic Strategy for Neurodegenerative Diseases?

The type 5 metabotropic glutamate receptor, mGlu5, has been proposed as a potential therapeutic target for the treatment of several neurodegenerative diseases. In preclinical neurodegenerative disease models, novel allosteric modulators have been shown to improve cognitive performance and reduce dis...

Full description

Saved in:
Bibliographic Details
Main Authors: Rebecca F. Budgett, Geor Bakker, Eugenia Sergeev, Kirstie A. Bennett, Sophie J. Bradley
Format: Artigo
Language:Inglês
Published: Frontiers Media S.A. 2022-05-01
Series:Frontiers in Pharmacology
Subjects:
GPCR
Alzheimer’s disease
neurodegenerative disease
neuroinflammation
G protein coupled receptors
drug discovery
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2022.893422/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items